{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:04:02Z","timestamp":1774987442330,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-174983"],"award-info":[{"award-number":["PJT-174983"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Legumain (Lgmn) is a virulence factor found in the protozoan parasites\n                    <jats:italic>Blastocystis<\/jats:italic>\n                    and\n                    <jats:italic>Trichomonas<\/jats:italic>\n                    , which affect both humans and animals. However, its specific targets and cytotoxic mechanisms on host cells are not well understood. Recent findings show that Lgmn cleaves PAR2 at the N\n                    <jats:sub>30<\/jats:sub>\n                    -R\n                    <jats:sub>31<\/jats:sub>\n                    residue, a site also targeted by L-asparaginase, a vital treatment for acute lymphoblastic leukemia (ALL), a severe hematologic cancer that poses high risks to children. This emphasizes the urgent need for more effective therapeutic strategies. Here, we demonstrate that Lgmn induces ER Ca\n                    <jats:sup>2+<\/jats:sup>\n                    release via the \u00b5-OR1-G\n                    <jats:sub>\u03b1i<\/jats:sub>\n                    and PAR2-G\n                    <jats:sub>\u03b1q<\/jats:sub>\n                    pathways. In PAR2-knockdown ALL cells, the stimulation of adenylate cyclase (AC) with forskolin or treatment with 8-CPT-cAMP effectively inhibits Lgmn-induced \u00b5-OR1-mediated ER Ca\n                    <jats:sup>2+<\/jats:sup>\n                    release, indicating that Lgmn\u2019s stimulation of \u00b5-OR1 results in the downregulation of AC and a subsequent decrease in cAMP levels. Additionally, the PKA-specific inhibitor 14\u201322 amide alone triggers ER Ca\n                    <jats:sup>2+<\/jats:sup>\n                    release, and subsequent treatment with Lgmn does not enhance this effect, suggesting that PKA inhibition plays a role and that the Lgmn-\u00b5-OR1-AC-cAMP axis can be bypassed in \u00b5-OR1-mediated ER Ca\n                    <jats:sup>2+<\/jats:sup>\n                    release. Furthermore, we observed a corresponding reduction in the phosphorylation of PLC\u03b23 at Ser1105 and BAD at Ser118, both of which are regulated by PKA. The Lgmn-induced ER Ca\n                    <jats:sup>2+<\/jats:sup>\n                    release ultimately leads to apoptosis in ALL cells, which can be reversed by blocking ER Ca\n                    <jats:sup>2+<\/jats:sup>\n                    release. Our results thus provide novel insights into the specific targets of Lgmn secreted from the protozoa and demonstrate how this virulence factor induces cytotoxic effects on host cells, paving the way for innovative therapeutic strategies for patients with ALL.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03003-3","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:15:16Z","timestamp":1772849716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lgmn targets two distinct GPCRs, PAR2 and \u00b5-OR1, and induces cell death in acute lymphoblastic leukemia through an intracellular Ca\u00b2\u207a imbalance triggered by ER Ca\u00b2\u207a release"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-2930","authenticated-orcid":false,"given":"Jung Kwon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5318-2536","authenticated-orcid":false,"given":"Karl","family":"Riabowol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5387-2692","authenticated-orcid":false,"given":"Ki-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"3003_CR1","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.1074\/jbc.272.12.8090","volume":"272","author":"JM Chen","year":"1997","unstructured":"Chen JM, Dando PM, Rawlings ND, Brown MA, Young NE, Stevens RA, et al. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem. 1997;272:8090\u20138. https:\/\/doi.org\/10.1074\/jbc.272.12.8090.","journal-title":"J Biol Chem"},{"key":"3003_CR2","doi-asserted-by":"publisher","first-page":"e52980","DOI":"10.1371\/journal.pone.0052980","volume":"8","author":"MH Haugen","year":"2013","unstructured":"Haugen MH, Johansen HT, Pettersen SJ, Solberg R, Brix K, Flatmark K, et al. Nuclear legumain activity in colorectal cancer. PLoS One. 2013;8:e52980 https:\/\/doi.org\/10.1371\/journal.pone.0052980.","journal-title":"PLoS One"},{"key":"3003_CR3","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1074\/jbc.M109.049064","volume":"285","author":"B Wu","year":"2010","unstructured":"Wu B, Yin J, Texier C, Roussel M, Tan KS. Blastocystis legumain is localized on the cell surface, and specific inhibition of its activity implicates a pro-survival role for the enzyme. J Biol Chem. 2010;285:1790\u20138. https:\/\/doi.org\/10.1074\/jbc.M109.049064.","journal-title":"J Biol Chem"},{"key":"3003_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0076-6879(94)44034-4","volume":"244","author":"ND Rawlings","year":"1994","unstructured":"Rawlings ND, Barrett AJ. Families of cysteine peptidases. Methods Enzymol. 1994;244:461\u201386. https:\/\/doi.org\/10.1016\/0076-6879(94)44034-4.","journal-title":"Methods Enzymol"},{"key":"3003_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02174042","volume":"6","author":"AJ Barrett","year":"1996","unstructured":"Barrett AJ, Rawlings ND. Families and clans of cysteine peptidases. Perspect Drug Discov Des. 1996;6:1\u201311. https:\/\/doi.org\/10.1007\/BF02174042.","journal-title":"Perspect Drug Discov Des"},{"key":"3003_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.parint.2012.02.007","volume":"61","author":"I Wawrzyniak","year":"2012","unstructured":"Wawrzyniak I, Texier C, Poirier P, Viscogliosi E, Tan KS, Delbac F, et al. Characterization of two cysteine proteases secreted by Blastocystis ST7, a human intestinal parasite. Parasitol Int. 2012;61:437\u201342. https:\/\/doi.org\/10.1016\/j.parint.2012.02.007.","journal-title":"Parasitol Int"},{"key":"3003_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1523\/JNEUROSCI.1211-20.2020","volume":"41","author":"NH Tu","year":"2021","unstructured":"Tu NH, Jensen DD, Anderson BM, Chen E, Jimenez-Vargas NN, Scheff NN, et al. Legumain induces oral cancer pain by biased agonism of protease-activated receptor-2. J Neurosci. 2021;41:193\u2013210. https:\/\/doi.org\/10.1523\/JNEUROSCI.1211-20.2020.","journal-title":"J Neurosci"},{"key":"3003_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41420-025-02467-z","volume":"11","author":"JK Lee","year":"2025","unstructured":"Lee JK, Riabowol K, Wang X, Lee KY. L-asparaginase is a PAR2 N-terminal protease that unmasks the PAR2 tethered ligand. Cell Death Discov. 2025;11:152 https:\/\/doi.org\/10.1038\/s41420-025-02467-z.","journal-title":"Cell Death Discov"},{"key":"3003_CR9","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1182\/blood-2018-12-890236","volume":"133","author":"JK Lee","year":"2019","unstructured":"Lee JK, Kang S, Wang X, Rosales JL, Gao X, Byun HG, et al. HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3\/12 pathway. Blood. 2019;133:2222\u201332. https:\/\/doi.org\/10.1182\/blood-2018-12-890236.","journal-title":"Blood"},{"key":"3003_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41420-024-02142-9","volume":"10","author":"JK Lee","year":"2024","unstructured":"Lee JK, Kamran H, Lee KY. L-asparaginase induces IP3R-mediated ER Ca(2+) release by targeting micro-OR1 and PAR2 and kills acute lymphoblastic leukemia cells. Cell Death Discov. 2024;10:366 https:\/\/doi.org\/10.1038\/s41420-024-02142-9.","journal-title":"Cell Death Discov"},{"key":"3003_CR11","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/OTT.S191621","volume":"12","author":"J Zhang","year":"2019","unstructured":"Zhang J, Gu Y, Chen B. Mechanisms of drug resistance in acute myeloid leukemia. Onco Targets Ther. 2019;12:1937\u201345. https:\/\/doi.org\/10.2147\/OTT.S191621.","journal-title":"Onco Targets Ther"},{"key":"3003_CR12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115:1363\u201381. https:\/\/doi.org\/10.1097\/ALN.0b013e318238bba6.","journal-title":"Anesthesiology"},{"key":"3003_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.18632\/oncotarget.952","volume":"4","author":"C Friesen","year":"2013","unstructured":"Friesen C, Roscher M, Hormann I, Fichtner I, Alt A, Hilger RA, et al. Cell death sensitization of leukemia cells by opioid receptor activation. Oncotarget. 2013;4:677\u201390. https:\/\/doi.org\/10.18632\/oncotarget.952.","journal-title":"Oncotarget"},{"key":"3003_CR14","doi-asserted-by":"publisher","first-page":"18023","DOI":"10.1074\/jbc.273.29.18023","volume":"273","author":"C Yue","year":"1998","unstructured":"Yue C, Dodge KL, Weber G, Sanborn BM. Phosphorylation of serine 1105 by protein kinase A inhibits phospholipase Cbeta3 stimulation by Galphaq. J Biol Chem. 1998;273:18023\u20137. https:\/\/doi.org\/10.1074\/jbc.273.29.18023.","journal-title":"J Biol Chem"},{"key":"3003_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1042\/0264-6021:3490547","volume":"349","author":"JM Lizcano","year":"2000","unstructured":"Lizcano JM, Morrice N, Cohen P. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J. 2000;349:547\u201357. https:\/\/doi.org\/10.1042\/0264-6021:3490547.","journal-title":"Biochem J"},{"key":"3003_CR16","doi-asserted-by":"publisher","first-page":"R883","DOI":"10.1016\/s0960-9822(00)00843-5","volume":"10","author":"K Virdee","year":"2000","unstructured":"Virdee K, Parone PA, Tolkovsky AM. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr Biol. 2000;10:R883 https:\/\/doi.org\/10.1016\/s0960-9822(00)00843-5.","journal-title":"Curr Biol"},{"key":"3003_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nature07396","volume":"455","author":"E Gavathiotis","year":"2008","unstructured":"Gavathiotis E, Suzuki M, Davis ML, Pitter K, Bird GH, Katz SG, et al. BAX activation is initiated at a novel interaction site. Nature. 2008;455:1076\u201381. https:\/\/doi.org\/10.1038\/nature07396.","journal-title":"Nature"},{"key":"3003_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbamcr.2010.12.019","volume":"1813","author":"D Westphal","year":"2011","unstructured":"Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of Bax and Bak activation and action. Biochim Biophys Acta. 2011;1813:521\u201331. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.12.019.","journal-title":"Biochim Biophys Acta"},{"key":"3003_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2020.102188","volume":"87","author":"AM Rossi","year":"2020","unstructured":"Rossi AM, Taylor CW. Reliable measurement of free Ca(2+) concentrations in the ER lumen using Mag-Fluo-4. Cell Calcium. 2020;87:102188. https:\/\/doi.org\/10.1016\/j.ceca.2020.102188.","journal-title":"Cell Calcium"},{"key":"3003_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80520-w","volume":"11","author":"J Lee","year":"2021","unstructured":"Lee J, Rosales JL, Byun HG, Lee KY. D,L-Methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca(2+) release and decrease in Ca(2+) efflux, elevating [Ca(2+)](i). Sci Rep. 2021;11:1009. https:\/\/doi.org\/10.1038\/s41598-020-80520-w.","journal-title":"Sci Rep"},{"key":"3003_CR21","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/ALN.0000000000002139","volume":"128","author":"A Furukawa","year":"2018","unstructured":"Furukawa A, Shinoda M, Kubo A, Honda K, Akasaka R, Yonehara Y, et al. Endothelin Signaling Contributes to Modulation of Nociception in Early-stage Tongue Cancer in Rats. Anesthesiology. 2018;128:1207\u201319. https:\/\/doi.org\/10.1097\/ALN.0000000000002139.","journal-title":"Anesthesiology"},{"key":"3003_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1124164","volume":"11","author":"JK Lee","year":"2023","unstructured":"Lee JK, Rosales JL, Lee KY. Requirement for ER-mitochondria Ca(2+) transfer, ROS production and mPTP formation in L-asparaginase-induced apoptosis of acute lymphoblastic leukemia cells. Front Cell Dev Biol. 2023;11:1124164. https:\/\/doi.org\/10.3389\/fcell.2023.1124164.","journal-title":"Front Cell Dev Biol"},{"key":"3003_CR23","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1038\/onc.2017.211","volume":"36","author":"SM Kang","year":"2017","unstructured":"Kang SM, Rosales JL, Meier-Stephenson V, Kim S, Lee KY, Narendran A. Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia. Oncogene. 2017;36:5910\u20133. https:\/\/doi.org\/10.1038\/onc.2017.211.","journal-title":"Oncogene"},{"key":"3003_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/bph.13237","volume":"173","author":"MM Muley","year":"2016","unstructured":"Muley MM, Reid AR, Botz B, B\u00f6lcskei K, Helyes Z, McDougall JJ. Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2. Br J Pharmacol. 2016;173:766\u201377. https:\/\/doi.org\/10.1111\/bph.13237.","journal-title":"Br J Pharmacol"},{"key":"3003_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41420-024-02028-w","volume":"10","author":"JK Lee","year":"2024","unstructured":"Lee JK, Wang X, Wang J, Rosales JL, Lee KY. PKA inhibition kills L-asparaginase-resistant leukemic cells from relapsed acute lymphoblastic leukemia patients. Cell Death Discov. 2024;10:257 https:\/\/doi.org\/10.1038\/s41420-024-02028-w.","journal-title":"Cell Death Discov"},{"key":"3003_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1388745","volume":"12","author":"H Kamran","year":"2024","unstructured":"Kamran H, Lee JK, Lee KY. PKA inhibition is a central step in D,L-methadone-induced ER Ca(2+) release and subsequent apoptosis in acute lymphoblastic leukemia. Front Cell Dev Biol. 2024;12:1388745. https:\/\/doi.org\/10.3389\/fcell.2024.1388745.","journal-title":"Front Cell Dev Biol"},{"key":"3003_CR27","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1073\/pnas.90.10.4708","volume":"90","author":"PA Sandstrom","year":"1993","unstructured":"Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc Natl Acad Sci USA. 1993;90:4708\u201312. https:\/\/doi.org\/10.1073\/pnas.90.10.4708.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3003_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cellsig.2004.11.008","volume":"17","author":"EH Wu","year":"2005","unstructured":"Wu EH, Wong YH. Pertussis toxin-sensitive Gi\/o proteins are involved in nerve growth factor-induced pro-survival Akt signaling cascade in PC12 cells. Cell Signal. 2005;17:881\u201390. https:\/\/doi.org\/10.1016\/j.cellsig.2004.11.008.","journal-title":"Cell Signal"},{"key":"3003_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-017-2879-z","volume":"10","author":"G Sanz","year":"2017","unstructured":"Sanz G, Leray I, Muscat A, Acquistapace A, Cui T, Rivi\u00e8re J, et al. Gallein, a Gbetagamma subunit signalling inhibitor, inhibits metastatic spread of tumour cells expressing OR51E2 and exposed to its odorant ligand. BMC Res Notes. 2017;10:541. https:\/\/doi.org\/10.1186\/s13104-017-2879-z.","journal-title":"BMC Res Notes"},{"key":"3003_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.bjp.0706711","volume":"148","author":"T Uemura","year":"2006","unstructured":"Uemura T, Kawasaki T, Taniguchi M, Moritani Y, Hayashi K, Saito T, et al. Biological properties of a specific Galpha q\/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress. Br J Pharmacol. 2006;148:61\u201369. https:\/\/doi.org\/10.1038\/sj.bjp.0706711.","journal-title":"Br J Pharmacol"},{"key":"3003_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1023\/a:1023684503883","volume":"23","author":"PA Insel","year":"2003","unstructured":"Insel PA, Ostrom RS. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol. 2003;23:305\u201314. https:\/\/doi.org\/10.1023\/a:1023684503883.","journal-title":"Cell Mol Neurobiol"},{"key":"3003_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/382083a0","volume":"382","author":"M Liu","year":"1996","unstructured":"Liu M, Simon MI. Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C. Nature. 1996;382:83\u201387. https:\/\/doi.org\/10.1038\/382083a0.","journal-title":"Nature"},{"key":"3003_CR33","doi-asserted-by":"publisher","first-page":"11012","DOI":"10.1074\/jbc.273.18.11012","volume":"273","author":"H Ali","year":"1998","unstructured":"Ali H, Sozzani S, Fisher I, Barr AJ, Richardson RM, Haribabu B, et al. Differential regulation of formyl peptide and platelet-activating factor receptors: role of phospholipase C\u03b23 phosphorylation by protein kinase A. J Biol Chem. 1998;273:11012\u20136. https:\/\/doi.org\/10.1074\/jbc.273.18.11012.","journal-title":"J Biol Chem"},{"key":"3003_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.neuropharm.2004.12.006","volume":"48","author":"GD Dalton","year":"2005","unstructured":"Dalton GD, Smith FL, Smith PA, Dewey WL. Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI). Neuropharmacology. 2005;48:648\u201357. https:\/\/doi.org\/10.1016\/j.neuropharm.2004.12.006.","journal-title":"Neuropharmacology"},{"key":"3003_CR35","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1126\/science.1846707","volume":"251","author":"AV Smrcka","year":"1991","unstructured":"Smrcka AV, Hepler JR, Brown KO, Sternweis PC. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science. 1991;251:804\u20137. https:\/\/doi.org\/10.1126\/science.1846707.","journal-title":"Science"},{"key":"3003_CR36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/350516a0","volume":"350","author":"SJ Taylor","year":"1991","unstructured":"Taylor SJ, Chae HZ, Rhee SG, Exton JH. Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. Nature. 1991;350:516\u20138. https:\/\/doi.org\/10.1038\/350516a0.","journal-title":"Nature"},{"key":"3003_CR37","doi-asserted-by":"publisher","first-page":"14217","DOI":"10.1016\/S0021-9258(18)98670-9","volume":"266","author":"GL Waldo","year":"1991","unstructured":"Waldo GL, Boyer JL, Morris AJ, Harden TK. Purification of an AlF4- and G-protein beta gamma-subunit-regulated phospholipase C-activating protein. J Biol Chem. 1991;266:14217\u201325.","journal-title":"J Biol Chem"},{"key":"3003_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1095\/biolreprod.107.064485","volume":"78","author":"M Zhong","year":"2008","unstructured":"Zhong M, Murtazina DA, Phillips J, Ku CY, Sanborn BM. Multiple signals regulate phospholipase CBeta3 in human myometrial cells. Biol Reprod. 2008;78:1007\u201317. https:\/\/doi.org\/10.1095\/biolreprod.107.064485.","journal-title":"Biol Reprod"},{"key":"3003_CR39","doi-asserted-by":"publisher","first-page":"798","DOI":"10.15252\/embj.201489056","volume":"34","author":"P Solanes","year":"2015","unstructured":"Solanes P, Heuz\u00e9 ML, Maurin M, Bretou M, Lautenschlaeger F, Maiuri P, et al. Space exploration by dendritic cells requires maintenance of myosin II activity by IP3 receptor 1. EMBO J. 2015;34:798\u2013810. https:\/\/doi.org\/10.15252\/embj.201489056.","journal-title":"EMBO J"},{"key":"3003_CR40","doi-asserted-by":"publisher","unstructured":"Arguello-Garcia R, Carrero JC, Ortega-Pierres MG. Extracellular cysteine proteases of key intestinal protozoan pathogens-factors linked to virulence and pathogenicity. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms241612850.","DOI":"10.3390\/ijms241612850"},{"key":"3003_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2004.03.002","volume":"335","author":"J Leon-Felix","year":"2004","unstructured":"Leon-Felix J, Ortega-Lopez J, Orozco-Solis R, Arroyo R. Two novel asparaginyl endopeptidase-like cysteine proteinases from the protist Trichomonas vaginalis: their evolutionary relationship within the clan CD cysteine proteinases. Gene. 2004;335:25\u201335. https:\/\/doi.org\/10.1016\/j.gene.2004.03.002.","journal-title":"Gene"},{"key":"3003_CR42","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/bph.12544","volume":"171","author":"MD Hollenberg","year":"2014","unstructured":"Hollenberg MD, Mihara K, Polley D, Suen JY, Han A, Fairlie DP, et al. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease. Br J Pharmacol. 2014;171:1180\u201394. https:\/\/doi.org\/10.1111\/bph.12544.","journal-title":"Br J Pharmacol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03003-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:22:14Z","timestamp":1774984934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3003"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03003-3","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}